News & Events

• January 23, 2023
  

  C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common Goals

      Critical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By combining C-Path’s unique global regulatory expertise and Mobilise-D’s focus on digital assessment of mobility, this mutually beneficial partnership aims to accelerate and improve the impact of these important initiatives that share common goals. The Critical Path for......
• March 28, 2022
  

  C-Path is proud to share our responses to the FDA draft guidance, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

  The Clinical Outcomes Assessment (COA), Critical Path for Parkinson’s Digital Drug Development (3DT) Initiative, and Type 1 Diabetes (T1D) Consortia all contributed to this effort, resulting in a combined set of comments on behalf of C-Path. By bringing together stakeholders across industry, regulatory agencies, patient groups, academic researchers and clinicians, disease foundations and other organizations......
• November 30, 2021
  

  Critical Path for Parkinson’s Shares Internship Highlights from Mikayla Spott

  Critical Path for Parkinson’s is proud to highlight Mikayla Spott who joined the team as CPP’s first consortium intern in August 2020. CPP was glad to play a part in her journey toward pursuing her dream of becoming a physician (and celebrates her recent acceptance to multiple medical schools!). “We are delighted to share her story and hope......
• March 18, 2021
  

  Welcome Dr. Martijn Muller as CPP Senior Scientific Director

  C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Prior to joining C-Path, Martijn was Research Associate Professor of Radiology and Co-Director of the Clinical and Neuroimaging Resource Cores of the Udall Center of Excellence for Parkinson’s disease Research at the University of Michigan. Dr. Muller has a diverse research background with an established publication record in neuropsychology, biomechanics, and neuroimaging.

• September 30, 2019
  

  The Critical Path for Parkinson’s Consortium (CPP) welcomes PMD Alliance as newest member

  The Critical Path for Parkinson’s Consortium (CPP) is thrilled to welcome the PMD Alliance (Parkinson & Movement Disorder Alliance) as our newest member. The PMD Alliance is an independent, national nonprofit organization that provides opportunities for people impacted by Parkinson’s and other movement disorders to learn, live life more fully, and connect with others. Their......